0001973379-24-000091.txt : 20240305
0001973379-24-000091.hdr.sgml : 20240305
20240305080435
ACCESSION NUMBER: 0001973379-24-000091
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Ascendis Pharma A/S
CENTRAL INDEX KEY: 0001612042
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: G7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-36815
FILM NUMBER: 24718345
BUSINESS ADDRESS:
STREET 1: TUBORG BOULEVARD 12
CITY: HELLERUP
STATE: G7
ZIP: DK-2900
BUSINESS PHONE: 45 70 22 22 44
MAIL ADDRESS:
STREET 1: TUBORG BOULEVARD 12
CITY: HELLERUP
STATE: G7
ZIP: DK-2900
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPROGOE KENNETT
CENTRAL INDEX KEY: 0001965630
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O ASCENDIS PHARMA A/S
STREET 2: TUBORG BOULEVARD 12
CITY: HELLERUP
STATE: G7
ZIP: DK-2900
144
1
primary_doc.xml
144
0001965630
XXXXXXXX
LIVE
0001612042
Ascendis Pharma A/S
001-36815
TUBORG BOULEVARD 12
HELLERUP
G7
DK-2900
45 70 22 22 44
SPROGOE KENNETT
Officer
Ordinary Shares
Citigroup Global Markets Inc.
390 Greenwich Street
New York
NY
10013
3892
583800.00
57707439
03/01/2024
NASDAQ
Ordinary Shares
03/01/2024
Restricted Stock Vesting
Ascendis Pharma A/S
N
6900
03/01/2024
Services Rendered
Y
The sales were completed according to 10B5-1 plans entered into in September 2023, for the sale of shares in connection to RSUs and PSUs vesting.
03/04/2024
Conformed Signature On File